The price of Leap Therapeutics Inc. (NASDAQ: LPTX) closed at 1.29 in the last session, down -0.77% from day before closing price of $1.30. In other words, the price has decreased by $-0.0100 from its previous closing price. On the day, 1193045 shares were traded. LPTX reached its highest trading level at $1.4100 during the session, while it also had its lowest trading level at $1.2601.
We take a closer look at LPTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.90 and its Current Ratio is at 8.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on October 04, 2021, initiated with a Buy rating and assigned the stock a target price of $6.
On June 29, 2020, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $6.Piper Sandler initiated its Overweight rating on June 29, 2020, with a $6 target price.
For the stock, the TTM Price-to-Sale (P/S) ratio is 104.36 while its Price-to-Book (P/B) ratio in mrq is 0.97.
Stock Price History:
Over the past 52 weeks, LPTX has reached a high of $4.17, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 1.1330, while the 200-Day Moving Average is calculated to be 1.8355.
According to the various share statistics, LPTX traded on average about 662.78K shares per day over the past 3-months and 559.6k shares per day over the past 10 days. A total of 88.99M shares are outstanding, with a floating share count of 70.67M. Insiders hold about 10.38% of the company’s shares, while institutions hold 56.60% stake in the company. Shares short for LPTX as of Jul 14, 2022 were 13.32M with a Short Ratio of 12.58, compared to 13.65M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 15.08% and a Short% of Float of 19.19%.
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of $-0.1 for the current quarter, with a high estimate of $-0.09 and a low estimate of $-0.11, while EPS last year was $-0.12. The consensus estimate for the next quarter is $-0.1, with high estimates of $-0.09 and low estimates of $-0.12.
Analysts are recommending an EPS of between $-0.37 and $-0.44 for the fiscal current year, implying an average EPS of $-0.4. EPS for the following year is $-0.45, with 5 analysts recommending between $-0.37 and $-0.59.